Company Description
Modern medicine is developed with an eye toward the new and improved future. Tongjitang Chinese Medicines looks to past. The company manufactures...
Headquarters:
5th Fl., Block B, Baiying Medical Device Park, Nanhai Avenue South, Nanshan DistrictShenzhen, Guangdong 518067, China
Key Tongjitang Chinese Medicines Financials
| Company Type | Public - NYSE: TCM Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $62.2 |
| 2005 Employees | 1,360 |
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Tongjitang Chinese Medicines's competition across multiple industries
Top Tongjitang Chinese Medicines Competitors
Editor-Selected Competitor List For Tongjitang Chinese Medicines
Sponsored Links
The Business DirectoryTrading Toolbox
Tongjitang Chinese Medicines Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Xiaochun Wang | Network | E-mail |
| CFO and Director | Wang Shaolan | Network | E-mail |
| CTO | Ling Qin | Network | E-mail |
More Tongjitang Chinese Medicines Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Tongjitang Chinese Medicines News
- Closing Update: Stocks Near Flat at Close - Dow Ends Q2 Down 7%, S&P Down 3% [Midnight Trader] (30 Jun 2008 16:14:00 EDT)
- Top Five Percentage Decliners By Volume on the NYSE [Midnight Trader] (30 Jun 2008 15:25:00 EDT)
- Stocks Higher at Mid-Day as Oil Prices Ease, Manufacturing Report Stronger Than Expected [Midnight Trader] (30 Jun 2008 11:57:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.